Legal Opinion
Bristol-Myers Squibb Co. v. Immunex Corp.
District Court, D. New Jersey
Decided February 29, 2000No. Civil Action 97-6050 (WHW), 98-159(WHW) and 98-1412 (WHW)PublishedCited by 2 opinions
1Opinion of the Court
OPINION
WALLS, District Judge.
IVAX Corporation, Baker Norton Pharmaceuticals, Inc., and Zenith Goldline Pharmaceuticals (collectively “IVAX”) move for leave to amend their counterclaims against Bristol-Myers Squibb. Having heard oral argument on February 14, 2000, and for reasons expressed in this opinion, the court denies the motion.
BACKGROUND
On January 4, 2000, this court granted the motion by plaintiff-counterclaim defendant Bristol-Myers Squibb Company (“Bristol”) to dismiss and strike all counterclaims of Baker Norton Pharmaceuticals and portions of counterclaims by Zenith Goldline…
2Cases cited11 opinions
- Foman v. DavisSupreme Court of the United States · 1962
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
- Kauffman v. MossCourt of Appeals for the Third Circuit · 1970
- Massarsky v. General Motors Corp.Court of Appeals for the Third Circuit · 1983
- Alfred Blasband v. Steven M. Rales Mitchell P. Rales John Doe 1-10 Danaher Corporation, Alfred Blasband, Derivatively on Behalf of Danaher CorporationCourt of Appeals for the Third Circuit · 1992
6 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- MUNICIPAL REVENUE SERVICE, INC. v. Xspand, Inc.District Court, M.D. Pennsylvania · 2010
- PETRI v. DRIVE NEW JERSEY INSURANCE COMPANYDistrict Court, D. New Jersey · 2024